Drug Class
immune checkpoint inhibitor
Type
ingredient
Active Ingredient
relatlimab
📋Overview
Relatlimab is a monoclonal antibody that targets the LAG-3 protein, which plays a role in regulating immune system activity. By blocking this protein, relatlimab can enhance the body's immune response against certain types of cancer cells. It is commonly associated with the treatment of advanced melanoma and is often studied in combination with other immunotherapies. Research continues to explore its effectiveness in various cancer types.
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Relatlimab
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.
